DeepMed Research

Galderma Group AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: -

Employees: -

Market Cap: $22.9B

Website: http://www.galderma.com/

Clinical Trials

Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing

Not Applicable

Recruiting

Conditions: Temple Hollowing

First Posted Date: 2024-10-30

Last Posted Date: 2025-01-17

Lead Sponsor: Galderma R&D

Target Recruit Count: 162

Registration Number: NCT06665477

Locations: 🇨🇳
Galderma Investigational Site #6340, Beijing, Beijing, China

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

Not Applicable

Completed

Conditions: Chin Augmentation

Interventions: Device: Restylane Shaype
Device: Restylane Defyne
Device: Restylane Lyft lidocaine

First Posted Date: 2024-05-24

Last Posted Date: 2025-01-31

Lead Sponsor: Galderma R&D

Target Recruit Count: 45

Registration Number: NCT06428214

Locations: 🇨🇦
Galderma Investigational Site 8379, Burlington, Ontario, Canada
🇨🇦
Galderma Investigational Site # 8754, Vancouver, British Columbia, Canada
🇨🇦
Galderma Investigational Site 8690, Westmount, Quebec, Canada

Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand

Not Applicable

Completed

Conditions: Skin Aging of Dorsal Hands

Interventions: Device: Restylane Skinboosters Vital Lidocaine
Device: Restylane Vital

First Posted Date: 2024-04-18

Last Posted Date: 2025-02-19

Lead Sponsor: Galderma R&D

Target Recruit Count: 90

Registration Number: NCT06372782

Locations: 🇨🇳
Galderma Research Site 01, Shanghai, Shanghai, China
🇨🇳
Galderma Research Site 02, Hangzhou, Zhejiang, China
🇨🇳
Galderma Research Site 03, Hangzhou, Zhejiang, China

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Phase 4

Completed

Conditions: Psoriasis
Plaque Psoriasis

Interventions: Drug: Cetaphil

First Posted Date: 2024-04-10

Last Posted Date: 2024-10-24

Lead Sponsor: Galderma R&D

Target Recruit Count: 46

Registration Number: NCT06357221

Locations: 🇺🇸
Southeast Dermatology Specialists, LLC, Douglasville, Georgia, United States
🇺🇸
Dermatology Consulting Services, High Point, North Carolina, United States

A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction

Not Applicable

Active, not recruiting

Conditions: Wrinkle

Interventions: Device: RHA3 Treatment in Nasolabial Fold
Device: Defyne Treatment in Nasolabial Fold

First Posted Date: 2024-04-08

Last Posted Date: 2024-10-24

Lead Sponsor: Galderma R&D

Target Recruit Count: 15

Registration Number: NCT06351293

Locations: 🇺🇸
The Aesthetic Clinique, Santa Rosa Beach, Florida, United States

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Not Applicable

Active, not recruiting

Conditions: Skin Laxity
Weight Loss
Photoaging
Photodamaged Skin
Volume Deficiency of the Midface

Interventions: Device: Sculptra treatment
Device: Restylane Treatment

First Posted Date: 2024-04-08

Last Posted Date: 2024-12-13

Lead Sponsor: Galderma R&D

Target Recruit Count: 40

Registration Number: NCT06351358

Locations: 🇺🇸
Somenek + Pittman MD: Advanced Plastic Surgery, Washington, District of Columbia, United States
🇺🇸
Lorenc Aesthetic Plastic Surgery Center, New York, New York, United States

A Controlled Study on Pain Management With Injection of Botulinum Toxin for Glabellar Line Correction

Phase 4

Completed

Conditions: Injection Site Discomfort

Interventions: Device: Vibrating Beauty Bar

First Posted Date: 2023-12-07

Last Posted Date: 2024-03-22

Lead Sponsor: Galderma R&D

Target Recruit Count: 60

Registration Number: NCT06161246

Locations: 🇺🇸
DeNova Research, Chicago, Illinois, United States

A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash

Phase 4

Completed

Conditions: Diaper Rash

Interventions: Drug: "Cetaphil Healing Ointment"

First Posted Date: 2023-08-29

Last Posted Date: 2024-04-11

Lead Sponsor: Galderma R&D

Target Recruit Count: 26

Registration Number: NCT06015217

Locations: 🇺🇸
Young Skin MD, Coral Springs, Florida, United States

Study to Evaluate the Safety and Effectiveness of GP0116

Not Applicable

Active, not recruiting

Conditions: Skin Manifestations

Interventions: Device: GP0116

First Posted Date: 2023-08-14

Last Posted Date: 2025-03-26

Lead Sponsor: Galderma R&D

Target Recruit Count: 186

Registration Number: NCT05987163

Locations: 🇺🇸
Galderma Investigational Site (Site#8074), Santa Monica, California, United States
🇺🇸
Galderma Investigational Site (Site#8478), Vista, California, United States
🇺🇸
Galderma Investigational Site (Site#8680), Westport, Connecticut, United States

and more 16 locations

A Study to Evaluate the Effects for Midface Improvement When Pairing a Biostimulator with a Skincare Regimen

Not Applicable

Completed

Conditions: Photodamaged Skin
Volume Deficiency of the Midface

Interventions: Combination Product: Sculptra and CeraVe Daily Moisturizing Lotion
Combination Product: Sculptra and Alastin Restorative Skin Complex

First Posted Date: 2023-07-27

Last Posted Date: 2024-10-24

Lead Sponsor: Galderma R&D

Target Recruit Count: 21

Registration Number: NCT05963204

Locations: 🇺🇸
Markowitz Medicals, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy